The federal minimum is six years after the completion of the research for most investigator-held records, but the requirement isn't one flat clock. Under the Common Rule at 45 CFR 46.115(b), institutions must retain IRB records — including correspondence and consent documents — for at least three years after the research ends, while 45 CFR 46.115(a) separately holds consent forms for three years after the research concludes. Investigator study files typically face longer clocks under 21 CFR 312.62(c) for drug trials and institutional policy that stretches toward six to ten years. Which number applies to you depends on your funder, your FDA obligations, and your institution's policy — and the longest one wins.

That's the boundary the rest of this article unpacks: not a single number, but a stack of overlapping retention rules where you comply with the highest bar and log the reasoning behind the choice.

Which Federal Rule Sets the Baseline: Common Rule Versus FDA

Two federal frameworks govern retention, and they don't match. The Common Rule at 45 CFR 46.115 covers IRB records and consent documentation for federally funded human subjects research and most institutional research regardless of funding. The FDA regulations at 21 CFR 312.62 and 812.140 cover investigational drugs, biologics, and devices, and they treat research records differently from IRB records.

Under 45 CFR 46.115(b), IRB records must be retained for at least three years after completion of the research. Those records include minutes, correspondence with investigators, consent form templates, and protocol documents the IRB reviewed. Under 21 CFR 312.62(c), investigators must retain records for two years after a marketing application is approved for the drug, or two years after the investigation is discontinued and FDA is notified if no application is approved. That FDA clock can stretch far longer than six years on a slow drug program.

The practical consequence: an investigator running an NIH-funded trial and an industry-sponsored IND at the same site answers to both clocks. Retention runs to whichever deadline falls latest, and the file can't be destroyed until every applicable rule, funder condition, and institutional requirement has expired.

The Six-Year Investigator Rule Most Sites Actually Follow

Most academic medical centers and research institutions impose a six-year default on investigator study records because it aligns with federal grant closeout and audit windows. This goes beyond what the Common Rule literally requires for investigator files, and it's usually written into institutional research policy rather than directly into federal regulation.

The number has a documented anchor in NIH grant administration. Under the NIH Grants Policy Statement, institutions must retain grant records for three years after submission of the final financial report, with the clock restarting if litigation or an audit is initiated. Combined with the Common Rule's three-year post-research minimum and FDA's variable timeline, six years has become the operational floor most research administrators apply to the entire study file, not just the grant ledger.

For an investigator, this means the consent documents, IRB approval letters, continuing review correspondence, protocol amendments, and adverse event logs all get the same default retention period at most sites — the longer of the institutional policy or the applicable regulation. Where policy and regulation conflict, the longer one binds, and the institution's research compliance office rather than the investigator makes that call.

Record Type Minimum Federal Clock Typical Institutional Clock Trigger That Starts the Clock
Signed consent documents 3 years (45 CFR 46.115(a)) 6 years Research completion
IRB correspondence and minutes 3 years (45 CFR 46.115(b)) 6 years Research completion
FDA drug study records 2 years post-approval or discontinuation (21 CFR 312.62(c)) 6+ years Marketing approval or discontinuation notice
Device study records 2 years post-approval or discontinuation (21 CFR 812.140(d)) 6+ years Marketing approval or discontinuation notice
NIH grant financial records 3 years post-final report (NIH Grants Policy Statement) 6 years Final financial report submission

Read the table by row: the institutional clock is not a federal requirement, but it's the one most investigators are actually audited against. If your site has no written policy, the federal minimum is the floor — and that's a risk, not a defense.

Where the Three-Year Clock Runs Out Before Your Audit Does

The three-year minimum creates a trap for investigators who assume "three years and I'm clear." Institutional audits, sponsor site visits, and federal inspections routinely happen inside the retention window, and a destroyed file turns a routine query into a finding.

Consider a device trial that finished in 2022. The FDA device rule at 21 CFR 812.140(d) requires records for two years after the investigation is terminated or the device's marketing application is approved, whichever is later. If the sponsor's PMA submission slipped, the investigator's clock could still be open in 2026 even though the Common Rule's three years expired in 2025. Destroying that file on the three-year anniversary wipes out records the sponsor or FDA can still demand.

Institutional policy usually resolves this by extending investigator records to at least six years and installing a hold flag for any study with pending publications, open data queries, sponsor audits, or regulatory submissions. Investigators rarely see the hold flag; they see a records management system that won't release a file for destruction until compliance clears it.

Two record types get separate treatment because the rules name them directly. Consent documents are covered by 45 CFR 46.115(a) with the three-year minimum. IRB correspondence — letters to investigators, minutes, protocol review notes — falls under 45 CFR 46.115(b). Both run from research completion, but they're stored in different places at many institutions, and that split causes real problems.

At most sites, the IRB office keeps the master file of correspondence and approved consent form templates. The investigator keeps signed consent forms and the site's copy of approval letters. When an audit occurs, the investigator is expected to produce both. If IRB correspondence was kept only at the IRB office and the research site never retained its own copy of approval letters, the site response depends on the IRB office's records management — a gap that shows up in FDA Form 483 observations at clinical sites.

The practical move is to treat IRB correspondence as part of the investigator's study file even though the regulation assigns retention to the institution. Duplicate the approval letters and continuing review correspondence into the site binder, and note in the file where the master copy lives.

How Long Does an Investigator Have to Keep Records After a Study Closes?

The clock starts at "completion of the research," a term that has no single federal definition and creates genuine ambiguity. Different funders and institutions define it differently: the last subject's last visit, the last data analysis, the final closeout report, or the grant's final financial report.

For most NIH-funded studies, the practical close is the submission of the final financial report, and the NIH Grants Policy Statement ties record retention to that event with a three-year minimum. For FDA-regulated trials, completion is usually the point at which the investigation is discontinued and FDA is notified, or marketing approval is granted. For an investigator records binder, the safest anchor is the last of these events, not the first.

That ambiguity also affects how you write your study closure documentation. If the file doesn't identify a specific closing event and date, the retention clock can't be calculated, and an auditor will default to the latest plausible date. Many site SOPs now require a "records retention start date" field in the closeout checklist, with the event that triggered it named explicitly.

What Happens If Records Are Destroyed Too Early

Destroying records inside the retention window is a compliance failure, not a housekeeping shortcut. Under FDA regulations, failure to maintain required records is a prohibited act that can support enforcement action against the investigator and the institution. Under the Common Rule's institutional assurance requirements, research records destruction without authorization can trigger institutional findings and threaten future federal funding.

The failure is usually procedural, not deliberate. A departing coordinator clears an office. A study coordinator retires and a lab manager discards boxes. A cloud storage account tied to a former employee auto-deletes after inactivity. Each of these is a retention failure that surfaces only when a sponsor audit or FDA inspection requests the file.

Investigator training rarely covers the retention clock in practical terms. If you run a study, treat the file as owned by the institution, not the coordinator, and move it into the institution's records management system at closeout rather than leaving it on a shared drive tied to one person's account.

When Institutional Policy Stretches Beyond Six Years

Many sites extend retention to ten years or longer for high-risk research categories: gene therapy, pediatric trials, device trials, and anything involving vulnerable populations or long-term follow-up. These extensions are usually written into the institutional research records policy or the IRB's record retention schedule, and they override the six-year default.

The extension frequently attaches to the consent document rather than the whole file. For gene therapy studies with long-term follow-up obligations, sites keep signed consent forms and the associated long-term follow-up records for the duration of the follow-up period plus the institutional retention clock. That can mean fifteen years or more from the last subject's enrollment.

Ask one question when planning a study: what does the institution's research records retention schedule say about this study category? The answer determines the file's lifespan more than any single federal regulation, and it's the number that shows up in internal audits.

How to Calculate Your Own Retention Deadline in Four Steps

The calculation isn't complicated once you identify the governing rules and the closing event. Run this sequence at study closeout and record the output in the file cover sheet.

1: Identify every applicable retention rule. List the Common Rule (45 CFR 46.115), any FDA regulation (21 CFR 312.62 or 812.140), the funder's policy, and the institution's research records retention schedule. Write each one's minimum retention period and specified starting trigger. 2: Pin down the closing event and date. Determine when the research is "completed" for each rule — last subject visit, final data lock, FDA discontinuation notice, or final financial report submission. Record the latest applicable date as your retention start date. 3: Calculate the latest deadline. Add the longest applicable retention period to the latest closing date. Ignore shorter deadlines if any longer rule applies to any record in the file. 4: Record the calculation and the destruction-hold status. Note the deadline on the file cover, confirm no audit holds or open data queries apply, and route destruction decisions through compliance rather than the coordinator.

If any step can't be completed, the file stays open. "No retention start date" is not a reason to release records for destruction.

Two failure scenarios are common in this calculation. First, a coordinator records the last subject visit as the closing date when the sponsor's final financial report won't be submitted for eight months, pulling the deadline forward prematurely. Second, an investigator assumes the three-year Common Rule clock on a device trial where the FDA regulation's approval trigger hasn't yet fired. Either mistake shortens the retention window below the true obligation.

Even though the regulations assign retention responsibilities to different parties, investigators should organize the file so all three record categories sit together. The typical structure puts signed consent forms in a subject-level binder, IRB approval letters and continuing review correspondence in an administrative section, and study data and adverse event records in a database section.

The consolidation matters because audits request the file as a unit. When FDA inspects a clinical site, the investigator response typically requires consent documents, IRB correspondence, protocol amendments, and study data simultaneously. A file organized by regulation rather than by study creates requests that chase records across offices.

Records systems that ship with site templates usually include a retention field tied to the institutional retention schedule, and that field should be populated at study start, not closeout. If your site doesn't have a template retention field, create a cover sheet with the calculation from the previous section and store it as page one.

FAQ

No. The federal minimum for IRB records and consent documents is three years after research completion under 45 CFR 46.115. The six-year number is an institutional default applied by most academic medical centers, not a federal statutory floor. Investigators whose site has no written policy are bound only by the federal minima and the funder's conditions — which is also the reason policy gaps create audit exposure.

Do I have to keep IRB correspondence, or does the IRB office keep it?

Federal retention responsibility sits with the institution under 45 CFR 46.115(b), usually delegated to the IRB office. Investigator files at audited sites still need to produce approval letters and continuing review determinations, which is why duplication of IRB correspondence into the site binder is standard practice. Check whether your SOP assigns duplicate retention to the site before relying on the IRB office alone.

What if my study is FDA-regulated and the marketing application was never approved?

Under 21 CFR 312.62(c), the clock runs two years from the date the investigation is discontinued and FDA is notified. A study that never reaches an approval application still owes records until that notification plus two years — and under institutional policy, usually longer. The investigator file remains open until each applicable clock expires, not until the first one does.

Can I destroy records after the retention period ends?

Only after the period runs out, no audit holds or open data queries apply, and compliance approves destruction. Destruction before the deadline is a prohibited act for FDA-regulated records and an institutional compliance finding under Common Rule obligations. Many sites require a documented destruction review even after the deadline, and that review is part of the file audit trail.

How does the NIH three-year rule for grant records differ from the research record rule?

Under the NIH Grants Policy Statement, financial and grant records must be retained for three years after submission of the final financial report, and the clock restarts if litigation or audit begins. That's a separate obligation from the human subjects research record retention under 45 CFR 46.115, and the two clocks can have different start dates and different end dates on the same study. Site SOPs generally resolve this by applying the later of the two deadlines to the whole file.

Do long-term follow-up studies extend the retention clock beyond six years?

Yes, when institutional policy attaches retention to the follow-up period. Gene therapy and pediatric studies frequently carry long-term follow-up obligations that balloon the file's lifespan to fifteen years or more, and the policy binding the investigator is the institutional research records schedule for that study category. Ask the research compliance office whether long-term follow-up retention attachments apply before assuming the six-year default.

What if a coordinator leaves and their cloud storage account gets deleted?

That's a retention failure whenever the account held study records still inside the clock. Under institutional records policy, records must live in the institution's designated system, not a personal drive or a coordinator's account, and the closeout process moves the file into that system before the coordinator rolls off. If you discover records on a departing staff member's account, transfer them to the institution's system immediately and document the transfer date.

Only three years under 45 CFR 46.115(a), unless a longer funder, FDA, or institutional rule applies. Since the FDA and most institutional policies extend that period, the practical consent-form retention at most sites lands at six years or longer. The three-year number is a floor, not a working deadline.

This article is general educational information about research records retention and not legal advice. Retention obligations vary by jurisdiction, funder, and institution, and investigators should confirm applicable deadlines with their research compliance office, IRB, and legal counsel before destroying or releasing any records.